There's been a notable change in appetite for Carl Zeiss Meditec AG shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approxi ...

ZEISS and Mindpeak partner to advance Multiplex Immunofluorescence (mIF) solutions for pathology ...